7595 logo

Pharmigene TPEX:7595 Stock Report

Last Price

NT$19.80

Market Cap

NT$999.2m

7D

-0.5%

1Y

-11.6%

Updated

26 Mar, 2024

Data

Company Financials

7595 Stock Overview

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.

7595 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Pharmigene, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Pharmigene
Historical stock prices
Current Share PriceNT$19.80
52 Week HighNT$25.70
52 Week LowNT$18.90
Beta0.14
1 Month Change-2.94%
3 Month Change-2.94%
1 Year Change-11.61%
3 Year Change-21.74%
5 Year Changen/a
Change since IPO-20.48%

Recent News & Updates

Recent updates

Shareholder Returns

7595TW BiotechsTW Market
7D-0.5%1.0%1.5%
1Y-11.6%-21.7%26.1%

Return vs Industry: 7595 exceeded the TW Biotechs industry which returned -21.7% over the past year.

Return vs Market: 7595 underperformed the TW Market which returned 26.1% over the past year.

Price Volatility

Is 7595's price volatile compared to industry and market?
7595 volatility
7595 Average Weekly Movement5.1%
Biotechs Industry Average Movement4.3%
Market Average Movement4.2%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 7595 has not had significant price volatility in the past 3 months.

Volatility Over Time: 7595's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994n/aSophia Zhanhttps://pharmigene.com.tw

Pharmigene, Inc. designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally. It offers molecular diagnostics to test adverse drug reactions; and DNA extraction products for gene expression analysis, clinical molecular diagnosis, human identity testing, forensics, and biomedical research applications. The company also provides pharmacogenomics test, drug allergy test, and functional medicine test services.

Pharmigene, Inc. Fundamentals Summary

How do Pharmigene's earnings and revenue compare to its market cap?
7595 fundamental statistics
Market capNT$999.21m
Earnings (TTM)-NT$48.46m
Revenue (TTM)NT$132.34m

7.6x

P/S Ratio

-20.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
7595 income statement (TTM)
RevenueNT$132.34m
Cost of RevenueNT$84.24m
Gross ProfitNT$48.10m
Other ExpensesNT$96.56m
Earnings-NT$48.46m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.96
Gross Margin36.34%
Net Profit Margin-36.62%
Debt/Equity Ratio169.4%

How did 7595 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.